Signal Advisors Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Signal Advisors Wealth's ABBV Position: Q2 2026 in Review
Signal Advisors Wealth increased its AbbVie (ABBV) stake by 95% in Q2 2026, buying an estimated $2.41M and bringing the position to 22,938 shares worth $5.77M. The position accounts for 0.29% of the portfolio, ranked #68.
Signal Advisors Wealth first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,222 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Signal Advisors Wealth held 22,938 shares of AbbVie worth $5.77M as of Q2 2026.
- Signal Advisors Wealth bought 11,190 AbbVie shares in Q2 2026, an estimated $2.41M.
- AbbVie made up 0.29% of Signal Advisors Wealth's portfolio in Q2 2026, its #68 holding.
- Signal Advisors Wealth first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
- 4,222 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Signal Advisors Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.